High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial
Project disclaimer
Description
MRC/JGHT 8 award phase III randomized, doubleblind placebocontrolled clinical trial evaluating whether ~3.5x higher oral doserifampicin has a 6month survival benefit as the primary endpoint, additionally pharmacokinetic measurements and safety are included as important secondary endpoints in Indonesia
Objectives
Research and development activity contributing to the UK’s strategy to address key development challenges.
Location
The country, countries or regions that benefit from this Programme.
Status Implementation
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Extending
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.
Download IATI Data for GB-GOV-13-OODA-MRC-7USD4VA-K8E2MJ9-S3ZD7T7